JPRN-UMIN000000849已完成4 期
A Randomized, Open Label, Multicenter Study Comparing the Safety and Efficacy of Once Daily Regimen Containing Epzicom or Truvada Combined with Ritonavir Boosted Atazanavir as Initial Therapy for HIV-1 Infection - ET Study
International Medical Center of Japan0 个研究点目标入组 240 人开始时间: 2007年10月15日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Current malabsorption condition, -Prior use of lamivudine for hepatitis B treatment, -Positive serology of Hepatitis B surface antigen, -Patients who have following abnormal laboratory results within 6 weeks prior enrollment; 1)alanine aminotransferaseis is more than 2.5 times higher of upper normal limit 2)estimated glomerular filtration rate is less than 60ml/min by Cockcroft-Gault equation 3)serum phosphate level is less than 2.0mg/dl -Patients with hemophilia, diabetes mellitus which require pharmacological treatment, congestive heart failure, cardiomyopathy or other serious medical condition -Patients in pregnancy, breast feeding, -Patients who are taking medicaitions contraindicated for combine use with study medicine -Patients whose primary care physicians consider inadequate to be enrolled
研究者
相似试验
进行中（未招募）
不适用
Comparison of efficacy and safety of OZURDEX® versus Lucentis® in the treatment of Diabetic Macular Edema.Diabetic Macular EdemaMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersEUCTR2011-005631-20-NLAllergan Ltd300
进行中（未招募）
1 期
Comparison of efficacy and safety of OZURDEX® versus Lucentis® in the treatment of Diabetic Macular Edema.Diabetic Macular EdemaMedDRA version: 15.0Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersEUCTR2011-005631-20-BEAllergan Ltd300
进行中（未招募）
不适用
Comparison of efficacy and safety of OZURDEX versus Lucentis in the treatment of Diabetic Macular Edema.Diabetic Macular EdemaMedDRA version: 14.1Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersEUCTR2011-005631-20-ITALLERGAN LIMITED300
进行中（未招募）
1 期
Comparison of efficacy and safety of OZURDEX® versus Lucentis® in the treatment of Diabetic Macular Edema.Diabetic Macular EdemaMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersEUCTR2011-005631-20-ESAllergan Ltd363
进行中（未招募）
不适用
Comparison of efficacy and safety of OZURDEX® versus Lucentis® in the treatment of Diabetic Macular Edema.Diabetic Macular EdemaMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersEUCTR2011-005631-20-ATAllergan Ltd300